Clinical Trial Update: Comparison of Paclitaxel-Coated Balloons Against Drug-Eluting Bioresorbable Scaffolds for Elective PCI Using OCT [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing paclitaxel-coated balloons to drug-eluting bioresorbable scaffolds in elective PCI has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• drug-eluting bioresorbable scaffolds (drug-eluting bioresorbable scaffolds)
• paclitaxel-coated balloons (paclitaxel-coated balloons)

Snippet

Sponsor: University of Jena | Conditions: Coronary Artery Disease | Phase 4 | Status: TERMINATED